This week we looked at perceived healthcare quality across selected European countries last year based on research conducted by market research company IPSOS.
Healthcare Activos has new investors as of today - and big plans for tomorrow and beyond. HBI catches up with its clearly enthused founder and executive chairman Jorge Guarner and CEO Albert Fernandez to find out more about their plans for expansion.
Multiple sources say US-based buyout specialist KKR is close to closing a deal to buy Spain-based global fertility player IVI-RMA, the largest group in the sector by revenue.
Now the largest unicorn in France, Doctolib is valued at €5.8b, three years after it reached unicorn status, despite still making a loss. HBI speaks to a French healthcare consultant and expert to find out how.
At the end of last year, healthcare specialist REIT Icade Santé looked to fall victim to capital markets' apathy for European healthcare services, postponing its IPO. Could it be looking to try again in H2 2022 - or is it too soon to try?
Almost a year after its IPO, lab giant Synlab has posted strong FY21 results bolstered by Covid, but not, it says, dependant on it. Management say extra cash will be used as a springboard for growth. Could it also lead to private equity majority shareholder Cinven selling its remaining interest?
Germany, France and Italy are Europe's largest for-profit laboratory services markets, with heavyweight groups like Sonic, Synlab, and Cerba having significant market shares. As the major players continue to make large and bolt-on acquisitions, just how consolidated are these markets.
The big diagnostic lab groups are on a frantic M&A drive to capture capacity in genetic testing. The deals reflect the hunger for specialist genetic doctors, biologists and counsellors in a manpower intensive field which is seeing explosive growth. We look at recent deals and name the new competitors who are entering the market.
Countries across Europe are turning to outsourcing to relieve the rapidly ramping up pressure on their public healthcare systems, as Omicron cases and staff absences mount. HBI hears the opportunities for for-profits to step in and help and substantial, and growing.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
